Cancer fighting T cells, the immune system’s primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma (ChRCC) and those that are present are indifferent to the ...

IND submitted to FDA for Eledon-sponsored, registrational study of tegoprubart in islet cell transplantation for patients with type 1 diabetes First patients enrolled in new investigator-initiated stu ...

The paired agents 68Ga and 177Lu-NYM096 target carbonic anhydrase IX (CAIX), an enzyme that is highly expressed in ccRCC.

Chronic kidney disease (CKD) is a major health burden affecting approximately one in 10 adults globally. Even with improved ...

As concerns rise about the effects of tiny plastic particles on human health, Flinders University researchers have led new research on whether nanoplastics can accumulate or cause damage in ...

Natural killer cells, also referred to as NK cells, play several major roles in the body's defense against cancers like renal cell carcinoma. Natural killer cells, also referred to as NK cells, play ...

Learn diagnosis, treatments, side effects and key questions to help guide shared decisions with your oncology team after stage 4 ccRCC diagnosis. Stage 4 clear cell renal cell carcinoma (ccRCC) is the ...

Eledon Pharmaceuticals, Inc. ( ELDN) announced significant progress in its Tegoprubart development programs, including submission of an Investigational New Drug (IND) application to the FDA for a ...

IND submitted to FDA for Eledon-sponsored, registrational study of tegoprubart in islet cell transplantation for patients with type 1 ...